Humacyte, Inc. (HUMA) Tops Q1 EPS by 48c

Humacyte, Inc. (NASDAQ: HUMA) reported Q1 EPS of $0.28, $0.48 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $517 thousand versus the consensus estimate of $764.83 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
• Abbott beats second-quarter estimates, raises 2026 guidance
• Ligand Pharma (LGND) PT Raised to $335 at Benchmark as XOMA Royalty Cash Acquisition Completed